EMEA-000733-PIP02-12

Key facts

Invented name
  • Osseor
  • Protelos
Active substance
Strontium (succinate)
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0022/2013
PIP number
EMEA-000733-PIP02-12
Pharmaceutical form(s)
  • Granules for oral suspension
  • Tablet
Condition(s) / indication(s)
Treatment of osteoporosis
Route(s) of administration
Oral use
Contact for public enquiries
Les Laboratoires Servier
E-mail: mail.pip.enquiries@fr.netgrs.com
Country: France
Tel. +33 155726000
Fax + 33 155725044
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating